November 22, 2021
The launch of the Longevity Biotechnology Association (LBA), announced on November 17th in London, looks like a tectonic shift for the longevity field. We have asked some of the founders about the rationale behind this unprecedented initiative and how it can change geroscience. A triple association "A scientist, a CEO, and an investor walk into...
April 28, 2021
BioAge Labs is off to a fast start in 2021, with two drugs in its pipeline now undergoing clinical trials and a third planned to start in the near future. BioAge Labs Building momentum After a $90 million Series C funding round closed late last year, BioAge has moved quickly to start the new year....
March 22, 2019
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech. We will be bringing you the latest aging research, investment, and business knowledge from some of the top...